EPISODE · Nov 5, 2023 · 7 MIN
New Insight: Phase 2 BEHOLD Study and UBX1325 for DME, Live at AAO 2023
from HCPLive Podcasts · host HCPLive.com
On the floor at AAO 2023, host Veeral Sheth, MD, and producer Connor Iapoce discuss UBX1325 for patients with diabetic macular edema, based on the 48-week results from the phase 2 BEHOLD study. Episode Highlights:0:30 Introduction0:48 Background into UBX1325 and BEHOLD2:49 BEHOLD 48-week results6:05 Next steps6:56 ConclusionPlease direct any podcast-related inquiries to [email protected].
NOW PLAYING
New Insight: Phase 2 BEHOLD Study and UBX1325 for DME, Live at AAO 2023
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m